26-A-14487-ACC COMPARATIVE OUTCOMES OF MAVACAMTEN VERSUS SEPTAL REDUCTION THERAPY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY: INSIGHTS FROM A PROPENSITY-MATCHED REAL-WORLD COHORT

View at publisher Summarise with VIRAT
Authors: Joe David Azzo, Charbel Nakhoul, Mario R. Caruso
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cardiomyopathy and Myosin Studies Cardiac Valve Diseases and Treatments Cardiac Arrhythmias and Treatments

Publication details

Journal / source
Journal of the American College of Cardiology
Volume
87
Issue
13
Pages
A733–A734
Publication date
27 March 2026
Language
EN